ATG-F4

N/A

Report date: 2025/01/26 15:06:13

Base Information

Drug NameATG-F4
Drug Alias NameLactobacillus reuteri probiotic (Atogen)ATG-F4
ClassificationBiologicsNatural product/Extract
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsSleep Wake DisordersSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtoGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAtoGen Co Ltd
Inactive CompaniesN/A
Active IndicationsSleep Wake DisordersSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A